1. A microRNA signature for valproate-induced steatosis in human hepatocytes and its application to predict fatty liver in paediatric epileptic patients on valproate therapy
   Polina Soluyanova et al, 2024, Toxicology CrossRef
2. A crosstalk between epigenetic modulations and non-alcoholic fatty liver disease progression
   Meysam Ramezani et al, 2023, Pathology - Research and Practice CrossRef
3. Underlying Mechanisms behind the Brain–Gut–Liver Axis and Metabolic-Associated Fatty Liver Disease (MAFLD): An Update
   Júlia Pauli De Cól et al, 2024, International Journal of Molecular Sciences CrossRef